Market Analysis

Explosive growth to push cancer vaccine market past $1B

Published in Vaccine Weekly, March 3rd, 2004

The worldwide market for cancer vaccines will experience explosive growth in the next few years, according to a new study released from Kalorama Information. Triple-digit growth will propel the market to surpass the $1 billion mark by 2008.

The new study, The Emerging Cancer Vaccines Market: Worldwide Developments and Potential Markets, forecasts that the next 3 years will be very important ones for cancer vaccines. From late 2004 through 2007, there will probably be more than a dozen product launches, most in areas that have not yet seen a vaccine-based therapies. In addition to the more well know products on the way for melanoma and cervical cancer, there are...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (2004-03-03)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry